Search
  • 网站搜寻
亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。
返回搜索结果

Novel Mithramycin Derivatives for Cancer Chemotherapy (2198)


技术优势

Key Advantages •     Improved selectivity for betterefficacy and fewer off-target effects•     Potential for less toxicity thanavailable chemotherapeutic agents currently in the clinic•     Better pharmacological propertiesthan current chemotherapies in use today


详细技术说明

The University of Kentucky is seeking a partner to further develop and commercializevarious mithramycin SA derivatives that were synthesized from a mithramycinSA-producing mutant. The derivatives of particular interest are thosecontaining the dipeptides L-Phe and L-Trp, and provide the potential for moreefficacious and less toxic chemotherapeutic interventions for Ewing’s Sarcoma.


国家/地区

美国

欲了解更多信息,请点击 这里
Business of IP Asia Forum
桌面版